The results of using a personalized treatment approach based on studying genetically determined metabolism of psychotropic drugs are presented. The data received evidences that this approach allows avoid adverse side effects as well as reduce significantly the time to achieving the treatment clinical effect.
Ключевые слова:Автор(ы): T. V. Dokukina, A. A. Gilep, T. S. Golubeva, I. V. Gaidukevich, I. I. Khvostova, M. V. Makhrov, T. O. Budko